DOI QR코드

DOI QR Code

Analysis of Patent Trends for Examination, Monitoring, and Healthcare of Parkinson's Disease

파킨슨병의 건강검진 및 일상 모니터링, 관리 기술의 특허 동향 분석

  • Received : 2020.12.04
  • Accepted : 2020.12.23
  • Published : 2020.12.30

Abstract

Objectives: Parkinson's disease (PD) is a neurodegenerative disease of the elderly characterized by impaired behavior from lack of dopamine secretion. However, no accurate quantitative diagnosis method has been established. The purpose of this study was to analyze the patent trends (PTs) of health examination and daily monitoring/healthcare technology for PD. Methods: For analyzing PTs, a search summary for classifying each analysis target technology was set, and a final search formula was constructed by collecting keywords. After constructing a database of related patents through the final search formula, noise was removed to extract valid patents. PTs by major countries were analyzed using the valid patents, and PTs and growth stages were analyzed by the detailed technologies. Results: The survey analysis showed that, despite the existence of unpublished patents between 2018 and 2020, patent activity has increased rapidly in the recent period, and this increasing trend was led by the USA. This technology is considered to be in its early- or mid-stage growth period, which means that the marketability is high and the barriers are low. Korea's market share is only about 25%, but it has a larger number of applications than those of Europe and Japan. Integrated monitoring and diagnosis technologies for PD have a share of 34%. Conclusion: The advances in diagnosis and healthcare technology for PD means that traditional Korean medicine must continue to pay attention to related technologies and to review plans that are applicable to clinical practice.

Keywords

References

  1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5(6):525-35. https://doi.org/10.1016/S1474-4422(06)70471-9
  2. Kim KS, Choi MA, Ha YS, Lee MS, Kim BJ, Kim SR, et al. Depression and Quality of Life among Family Caregivers of Patients with Parkinson's Disease in South Korea. Korean J Rehabil Nurs 2007;10(2):90-9.
  3. Park SM, Kwak YS. The Scientific Analysis of the Parkinson's Disease Treatment and Prevention. J Coaching Development 2014;16(4):133-42.
  4. Song IU, Ryu SY, Lee KS, Yoo JY, Kim YI, Kim HT, et al. The Prevalence of Risk Factors for Vascular Disease in Parkinson's Disease; Comparison with Normal Controls and Disease Controls. J Korean Geriatr Soc 2006;10(4):296-300.
  5. Jung JC, Kim KH, Park SM, Lee SH, Chang DI, Lee YH. The Study on the Distribution of Sasang Constitution and UPDRS(Unified Parkinson's Disease Rating Scale) among Parkinson's Disease Patients. J Acupunct Res 2005;22(4):47-54.
  6. Kang DY, Cheon SM, Cheon SM, Lee KS, Kim K. Correlations among Respiratory Function, UPDRS and Senior Fitness in Parkinson's Disease Patients. J Korean Soc Phys Ther 2014;26(2):48-55.
  7. Ho SH, Song IU, Chung YA. Prognostic Evaluation through Cardiac 123I-Metaiodobenzylguanidine Image in Parkinson's Disease (Pilot Study). Korean J Clinical Geriatrics 2016;17(2):74-8. https://doi.org/10.15656/kjcg.2016.17.2.74
  8. Kim JS, Park CR. The Study of Radiation Exposure Reduction by Developing Corpus Striatum Phantom. J radiological science and technology 2017;40(4):595-603. https://doi.org/10.17946/JRST.2017.40.4.09
  9. Dijkstra B, Kamsma YP, Zijlstra W. Detection of Gait and Postures Using a Miniaturized Triaxial Accelerometer-Based System: Accuracy in Patients with Mild to Moderate Parkinson's Disease. Archives of Physical Medicine and Rehabilitation 2010;91(8):1272-7. https://doi.org/10.1016/j.apmr.2010.05.004
  10. Berardelli A, Rothwell JC, Day BL, Marsden CD. Movements not Involved in Posture are Abnormal in Parkinson's Disease. Neurosci Lett 1984;47(1):47-50. https://doi.org/10.1016/0304-3940(84)90384-7
  11. Mirelman A, Herman T, Nicolai S, Zijlstra A, Zijlstra W, Becker C, et al. Audio-Biofeedback Training for Posture and Balance in Patients with Parkinson's Disease. J Neuroeng Rehabil 2011;8:35. https://doi.org/10.1186/1743-0003-8-35
  12. Constantinescu R, Leonard C, Deeley C, Kurlan R. Assistive Devices for Gait in Parkinson's Disease. Parkinsonism Relat Disord 2007;13(3):133-8. https://doi.org/10.1016/j.parkreldis.2006.05.034
  13. McCandless PJ, Evans BJ, Janssen J, Selfe J, Churchill A, Richards J. Effect of Three Cueing Devices for People with Parkinson's Disease with Gait Initiation Difficulties. Gait Posture 2016;44:7-11. https://doi.org/10.1016/j.gaitpost.2015.11.006
  14. Thompson E, Agada P, Wright WG, Reimann H, Jeka J. Spatiotemporal Gait Changes with Use of an Arm Swing Cueing Device in People with Parkinson's Disease. Gait Posture 2017;58:46-51. https://doi.org/10.1016/j.gaitpost.2017.07.001
  15. Schulza GM, Grant MK. Effects of Speech Therapy and Pharmacologic and Surgical Treatments on Voice and Speech in Parkinson's Disease: A Review of the Literature. J Commun Disord 2000;33(1):59-88. https://doi.org/10.1016/S0021-9924(99)00025-8
  16. Schalling E, Gustafsson J, Ternstrom S, Wilen FB, Sodersten M. Effects of Tactile Biofeedback by a Portable Voice Accumulator on Voice Sound Level in Speakers with Parkinson's Disease. J Voice 2013;27(6):729-37. https://doi.org/10.1016/j.jvoice.2013.04.014
  17. Sapir S, Ramig LO, Fox C. The Lee Silverman Voice Treatment® for Voice, Speech and Other Orofacial Disorders in Patients with Parkinson's Disease. Future Neurology 2006;1(5):563-70. https://doi.org/10.2217/14796708.1.5.563
  18. Ramig LO, Fox C, Sapir S. Speech Disorders in Parkinson's Disease and the Effects of Pharmacological, Surgical and Speech Treatment with Emphasis on Lee Silverman Voice Treatment (LSVT®). Handb Clin Neurol 2007;83:385-99. https://doi.org/10.1016/S0072-9752(07)83017-X
  19. Andreetta MD, Adams SG, Dykstra AD, Jog M. Evaluation of Speech Amplification Devices in Parkinson's Disease. Am J Speech Lang Pathol 2016;25(1):29-45. https://doi.org/10.1044/2015_AJSLP-15-0008
  20. Bowers D, Miller K, Bosch W, Gokcay D, Pedraza O, Springer U, et al. Faces of Emotion in Parkinson's Disease: Micro-Expressivity and Bradykinesia during Voluntary Facial Expressions. J Int Neuropsychol Soc 2006;12(6):765-73. https://doi.org/10.1017/S135561770606111X
  21. Katsikitis M, Pilowsky I. A Study of Facial Expression in Parkinson's Disease Using a Novel Microcomputer-Based Method. J Neurol Neurosurg Psychiatry 1988;51(3):362-6. https://doi.org/10.1136/jnnp.51.3.362
  22. Sam-O International Patent & Law Office, Analysis of Patent Trends for Examination, Daily Monitoring and Healthcare of Parkinson's Disease Impeding Economic Activity. Survey Report of Patent Trend for Korea Medical Device Development. Seoul: KISTA; 2020.
  23. Kim JS. Future Strategies of Research Investment for the Latest Treatment of Parkinson's Disease. Seoul: The Korean Movement Disorder Society; 2017.
  24. Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (an Evidence-Based Review). Neurology 2006;66(7):976-82. https://doi.org/10.1212/01.wnl.0000206363.57955.1b
  25. Lee JE, Choi J, Lim HS, Kim JH, Cho JH, Kim GS, et al. The Prevalence and Incidence of Parkinson's Disease in South Korea: A 10-Year Nationwide Population-Based Study. J Korean Neurol Assoc 2017;35(4):191-8. https://doi.org/10.17340/jkna.2017.4.1
  26. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 2007;22(16):2314-24. https://doi.org/10.1002/mds.21844